| Financial Year |
March 31 2023 |
| Monetary Funds |
1,315,558,357.82 |
| Held-for-trading Financial Assets |
150,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
467,456,038.08 |
| Advances to Suppliers |
440,709,315.72 |
| Other Receivables |
118,061,272.88 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,776,305,656.86 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
400,001,493.34 |
| Total Current Assets |
5,963,335,868.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
24,499,016.01 |
| Investment Properties |
-- |
| Fixed Assetes |
6,897,345,901.11 |
| Under-construction Projects |
1,245,766,192.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
149,170.26 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,342,514,673.84 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
40,879,507.19 |
| Deferred Income Tax Assets |
87,799,135.41 |
| Other Non-Current Assets |
233,117,771.74 |
| Sub-Total of Non-Current Assets |
10,064,260,902.54 |
| Total Assets |
16,027,596,770.93 |
| Short-Term Loans |
2,094,865.14 |
| Trading Financial liabilities |
-- |
| Notes Payable |
242,831,633.80 |
| Accounts Payable |
2,149,717,551.29 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
120,779,842.40 |
| Taxes Payable |
158,665,850.68 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
832,010,386.59 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
30,483.77 |
| Other Current Liabilities |
114,430,245.67 |
| Sub-Total of Current Liabilities |
4,892,008,033.41 |
| Long-term Loans |
300,000,000.00 |
| Bonds Payable |
973,939,559.25 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
90,944,213.17 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,707,213,317.95 |
| Total Liabilities |
6,599,221,351.36 |
| Paid-In Capital(Or Share Stock) |
1,332,897,010.00 |
| Capital Surplus |
160,413,453.33 |
| Surplus Reserve |
652,264,645.00 |
| LESS:Treasury Stock |
477,696,055.01 |
| Undistributed Profits |
7,076,750,834.40 |
| Minority Stockholder's Interest |
435,975,289.81 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,992,400,129.76 |
| Owner's Equity（Stockholder's Equity） |
9,428,375,419.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
16,027,596,770.93 |
